Kalvista Pharmaceuticals, Inc.
KALV
Revenue
13.69M
▲12.29M▲878.00%
2 Months ChangeAssets
339.93M
▲124.43M▲57.74%
2 Months ChangeLiabilities
322.93M
▲192.48M▲147.54%
9 Months ChangeFree Cash Flow
-54.79M
▼-14.55M▼-36.16%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-04
Form 8-K
ID: 0000950170-24-112904
2024-09-10
Form 8-K
ID: 0000950170-24-105182
2024-09-05
Form 8-K
ID: 0000950170-24-104032
2024-09-05
Form 10-Q
ID: 0000950170-24-103981
2024-07-23
Form 8-K
ID: 0000950170-24-085653
2024-07-11
Form 8-K
ID: 0000950170-24-082997
2024-04-22
Form 8-K
ID: 0000950170-24-046481
2024-03-11
Form 8-K
ID: 0000950170-24-029342
2024-03-11
Form 10-Q
ID: 0000950170-24-029314
2024-03-07
Form 8-K
ID: 0001193125-24-061344